Role of MAGI2-AS3 in malignant and non-malignant disorders

被引:2
作者
Taheri, Mohammad [1 ,2 ]
Askari, Arian [3 ]
Hussen, Bashdar Mahmud [4 ]
Ghafouri-Fard, Soudeh [5 ]
Rashnoo, Fariborz [6 ]
机构
[1] Jena Univ Hosp, Inst Human Genet, Jena, Germany
[2] Shahid Beheshti Univ Med Sci, Urol & Nephrol Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Phytochemistry Res Ctr, Tehran, Iran
[4] Hawler Med Univ, Coll Pharm, Dept Clin Anal, Erbil, Kurdistan Regio, Iraq
[5] Shahid Beheshti Univ Med Sci, Sch Med, Dept Med Genet, Tehran, Iran
[6] Shahid Beheshti Univ Med Sci, Loghman Hakim Hosp, Tehran, Iran
关键词
MAGI2-AS3; lncRNA; Cancer; Expression; Biomarker; NONCODING RNA MAGI2-AS3; LNCRNA MAGI2-AS3; CANCER PROGRESSION; CARCINOMA; INVASION; PROLIFERATION; SUPPRESSES; MIGRATION;
D O I
10.1016/j.prp.2023.154530
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
MAGI2 Antisense RNA 3 (MAGI2-AS3) is a long non-coding RNA (lncRNA) transcribed from a locus on 7q21.11. This lncRNA has been described to be abnormally expressed in a variety of malignancies in correlation with many clinical characteristics. Moreover, it might participate in the pathogenesis of congenital diaphragmatic hernia, Alzheimer's disease and intervertebral disc degeneration. Mechanistically, MAGI2-AS3 can serve as a molecular sponge for miR-142-3p, miR-424-5p, miR-15b, miR-233, miR-452-5p, miR-629-5p, miR-25, miR-155, miR-23a-3p, miR-519c-3p, miR-374b-5p, miR-374a, miR-31-5p, miR-3163, miR-525-5p, miR-15-5p, miR-374a-5p, miR-374b-5p, miR-218-5p, miR-141-3p and miR-200a-3p to regulate expression of their mRNA targets. The current review summarizes the role of MAGI2-AS3 in different disorders to highlight its importance in their pathophysiology.
引用
收藏
页数:9
相关论文
共 48 条
  • [1] Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients
    Cai, Jiarong
    Chen, Zheng
    Chen, Xuelian
    Huang, He
    Lin, Xia
    Miao, Bin
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [2] RETRACTED: LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical Cancer by Sponging MiR-15b (Retracted Article)
    Chai, Yiqing
    Wang, Lili
    Qu, Yanwen
    Hu, Zhixia
    [J]. JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [3] MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis
    Chang, Hua
    Zhang, Xue
    Li, Baixue
    Meng, Xiangkai
    [J]. CANCER MEDICINE, 2020, 9 (17): : 6377 - 6386
  • [4] LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia
    Chen, Lijuan
    Fan, Xu
    Zhu, Jianhua
    Chen, Xuexin
    Liu, Yiling
    Zhou, Hao
    [J]. RNA BIOLOGY, 2020, 17 (06) : 784 - 793
  • [5] Chen XD, 2019, EUR REV MED PHARMACO, V23, P3455, DOI 10.26355/eurrev_201904_17710
  • [6] LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7 via EZH2
    Cheng, Wenfang
    Shi, Xiuling
    Lin, Mingqiang
    Yao, Qiwei
    Ma, Jiayu
    Li, Jiancheng
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [7] LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells
    Cui, Shuting
    Liu, Zizhen
    Tang, Bin
    Wang, Zhizhen
    Li, Baojian
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2020, 21 (01)
  • [8] Dianatpour A, 2017, INT J MOL CELL MED, V6, P1, DOI 10.22088/acadpub.BUMS.6.1.1
  • [9] Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA3
    Du, Qiong
    Ye, Xuan
    Lu, Sheng-Rong
    Li, Huan
    Liu, Hong-Yue
    Zhai, Qing
    Yu, Bo
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (01) : 52 - 68
  • [10] Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a
    Du, Shanmei
    Hu, Wei
    Zhao, Yi
    Zhou, Hengzhong
    Wen, Wei
    Xu, Miao
    Zhao, Peiqing
    Liu, Kui
    [J]. CANCER BIOMARKERS, 2019, 24 (03) : 269 - 277